# Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

> **NCT01189695** · PHASE4 · COMPLETED · sponsor: **Bamrasnaradura Infectious Diseases Institute** · enrollment: 63 (actual)

## Conditions studied

- HIV
- AIDS
- Lopinavir
- Treatment Failure

## Interventions

- **DRUG:** Ritonavir-boosted lopinavir
- **DRUG:** optimized background regimens (OBRs)

## Key facts

- **NCT ID:** NCT01189695
- **Lead sponsor:** Bamrasnaradura Infectious Diseases Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2013-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01189695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01189695, "Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01189695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*